Table of Contents Author Guidelines Submit a Manuscript
Neuroscience Journal
Volume 2015, Article ID 368989, 5 pages
http://dx.doi.org/10.1155/2015/368989
Research Article

Change in Motor and Nonmotor Symptoms Severity in a “Real-Life” Cohort of Subjects with Parkinson’s Disease

1Clinical Neurodegenerative Research Unit, National Institute of Neurology and Neurosurgery, 3877 Insurgentes Sur, Tlalpan, 14269 Mexico City, DF, Mexico
2Movement Disorder Clinic, National Institute of Neurology and Neurosurgery, 3877 Insurgentes Sur, Tlalpan, 14269 Mexico City, DF, Mexico

Received 3 June 2015; Accepted 16 August 2015

Academic Editor: Pasquale Striano

Copyright © 2015 Adib Jorge de Saráchaga et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Jankovic, “Parkinson's disease: clinical features and diagnosis,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 79, no. 4, pp. 368–376, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Kuramoto, J. Cragg, R. Nandhagopal et al., “The nature of progression in Parkinson's disease: an application of non-linear, multivariate, longitudinal random effects modelling,” PLoS ONE, vol. 8, no. 10, Article ID e76595, 2013. View at Publisher · View at Google Scholar
  3. J. R. Evans, S. L. Mason, C. H. Williams-Gray et al., “The natural history of treated Parkinson's disease in an incident, community based cohort,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 82, no. 10, pp. 1112–1118, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Reinoso, J. C. Allen, W.-L. Au, S.-H. Seah, K.-Y. Tay, and L. C. S. Tan, “Clinical evolution of Parkinson's disease and prognostic factors affecting motor progression: 9-year follow-up study,” European Journal of Neurology, vol. 22, no. 3, pp. 457–463, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Jankovic and A. S. Kapadia, “Functional decline in Parkinson disease,” Archives of Neurology, vol. 58, no. 10, pp. 1611–1615, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. W. Poewe, R. A. Hauser, and A. Lang, “Effects of rasagiline on the progression of nonmotor scores of the MDS-UPDRS,” Movement Disorders, vol. 30, pp. 589–592, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. A. E. Lang, S. Eberly, C. G. Goetz et al., “Movement disorder society unified parkinson disease rating scale experiences in daily living: Longitudinal changes and correlation with other assessments,” Movement Disorders, vol. 28, no. 14, pp. 1980–1986, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. I. G. Smolentseva, L. P. Chupina, N. A. Amosova, and O. V. Krivonos, “Clinical evaluation of Parkinson's disease progression,” Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova, vol. 114, pp. 36–40, 2014. View at Google Scholar · View at Scopus
  9. P. Martínez-Martín, C. Rodríguez-Blázquez, M. Alvarez et al., “Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale,” Parkinsonism and Related Disorders, vol. 21, no. 1, pp. 50–54, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. A. J. Hughes, S. E. Daniel, L. Kilford, and A. J. Lees, “Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases,” Journal of Neurology Neurosurgery and Psychiatry, vol. 55, no. 3, pp. 181–184, 1992. View at Publisher · View at Google Scholar · View at Scopus
  11. C. L. Tomlinson, R. Stowe, S. Patel, C. Rick, R. Gray, and C. E. Clarke, “Systematic review of levodopa dose equivalency reporting in Parkinson's disease,” Movement Disorders, vol. 25, no. 15, pp. 2649–2653, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Martinez-Martin, C. Rodriguez-Blazquez, M. Alvarez-Sanchez et al., “Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS),” Journal of Neurology, vol. 260, no. 1, pp. 228–236, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. V. Peto, C. Jenkinson, and R. Fitzpatrick, “PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures,” Journal of Neurology, vol. 245, pp. S10–S14, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. K. R. Chaudhuri, P. Martinez-Martin, R. G. Brown et al., “The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study,” Movement Disorders, vol. 22, no. 13, pp. 1901–1911, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Martinez-Martin, K. R. Chaudhuri, J. M. Rojo-Abuin et al., “Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale,” European Journal of Neurology, vol. 22, no. 1, pp. 37–43, 2015. View at Publisher · View at Google Scholar · View at Scopus